Northern Trust’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-797,888
| Closed | -$14.2M | – | 4335 |
|
|
2018
Q3 | $14.2M | Buy |
797,888
+15,441
| +2% | +$265K | ﹤0.01% | 2036 |
|
|
2018
Q2 | $10.8M | Buy |
782,447
+652,821
| +504% | +$7.75M | ﹤0.01% | 2224 |
|
|
2018
Q1 | $1.18M | Buy |
129,626
+48,770
| +60% | +$269K | ﹤0.01% | 3333 |
|
|
2017
Q4 | $346K | Buy |
80,856
+1,820
| +2% | +$8.67K | ﹤0.01% | 3644 |
|
|
2017
Q3 | $112K | Sell |
79,036
-3
| -0% | -$4 | ﹤0.01% | 3928 |
|
|
2017
Q2 | $119K | Sell |
79,039
-317,009
| -80% | -$681K | ﹤0.01% | 3933 |
|
|
2017
Q1 | $1.02M | Buy |
396,048
+1,278
| +0.3% | +$2.96K | ﹤0.01% | 3345 |
|
|
2016
Q4 | $1.01M | Buy |
394,770
+13,108
| +3% | +$37.6K | ﹤0.01% | 3347 |
|
|
2016
Q3 | $1.18M | Buy |
381,662
+1,603
| +0.4% | +$5K | ﹤0.01% | 3295 |
|
|
2016
Q2 | $1.22M | Buy |
380,059
+20,206
| +6% | +$74.1K | ﹤0.01% | 3285 |
|
|
2016
Q1 | $1.12M | Buy |
359,853
+1,598
| +0.4% | +$5.22K | ﹤0.01% | 3216 |
|
|
2015
Q4 | $1.44M | Sell |
358,255
-3,746
| -1% | -$17.3K | ﹤0.01% | 3193 |
|
|
2015
Q3 | $1.66M | Sell |
362,001
-51,046
| -12% | -$267K | ﹤0.01% | 3139 |
|
|
2015
Q2 | $2.14M | Buy |
413,047
+19,891
| +5% | +$119K | ﹤0.01% | 3021 |
|
|
2015
Q1 | $2.46M | Sell |
393,156
-1,538
| -0.4% | -$8.88K | ﹤0.01% | 3002 |
|
|
2014
Q4 | $2.48M | Sell |
394,694
-15,250
| -4% | -$93K | ﹤0.01% | 2960 |
|
|
2014
Q3 | $2.49M | Buy |
409,944
+5,847
| +1% | +$39.9K | ﹤0.01% | 2957 |
|
|
2014
Q2 | $2.66M | Sell |
404,097
-3,770
| -0.9% | -$42.5K | ﹤0.01% | 2907 |
|
|
2014
Q1 | $9.71M | Sell |
407,867
-34,318
| -8% | -$498K | ﹤0.01% | 2128 |
|
|
2013
Q4 | $4.72M | Buy |
442,185
+8,688
| +2% | +$95.9K | ﹤0.01% | 2611 |
|
|
2013
Q3 | $5.78M | Buy |
433,497
+15,124
| +4% | +$239K | ﹤0.01% | 2410 |
|
|
2013
Q2 | $5.49M | Buy |
+418,373
| New | +$5.64M | ﹤0.01% | 2337 |
|
Other funds holding ECYT
Northern Trust's ECYT Position: Q4 2018 in Review
Northern Trust sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 797,888 shares — an estimated $14.2M sold.
Northern Trust first reported a position in ECYT in Q2 2013 and held it in 22 quarters. The position peaked at $14.2M in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.
- Northern Trust reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
- Northern Trust sold 797,888 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $14.2M.
- Northern Trust first reported a position in Endocyte, Inc. Common Stock in Q2 2013 and held it in 22 quarters.
- Northern Trust's Endocyte, Inc. Common Stock position peaked at $14.2M in Q3 2018.
- 2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.
Based on Northern Trust's 13F filing for Q4 2018, filed 12 Feb 2019.